01778nas a2200385   4500000000100000008004100001260001700042653001000059653002600069653003200095653001100127653002900138653003200167653001100199653002300210653001200233653002400245653002500269653002500294653000900319653001600328653002700344653003000371653003000401100001600431700001200447700001400459700001500473245004400488300001100532490000700543050003200550520079600582022001401378       1990                            d  c1990 Oct-Dec10aAdult10aAudiometry, Pure-Tone10aEvaluation Studies as Topic10aFemale10aHearing Loss, Conductive10aHearing Loss, Sensorineural10aHumans10aLeprostatic Agents10aleprosy10aLeprosy, Borderline10aLeprosy, lepromatous10aLeprosy, Tuberculoid10aMale10aMiddle Aged10aNystagmus, Physiologic10aOtitis Media, Suppurative10aVestibular Function Tests1 aAwasthi S K1 aSingh G1 aDutta R K1 aPahuja O P00aAudiovestibular involvement in leprosy.  a429-340 v62  aInfolep Library - available3 a<p>100 leprosy patients were studied for audiovestibular involvement. Conductive hearing loss was detected in 6 cases of BT leprosy, all of them having coincidental chronic middle ear infection. Sensori-neural hearing loss was detected in 10 cases, of which 6 had LL, 2 BT and 2 pure neuritic type of disease respectively. All the cases of lepromatous leprosy having sensorineural hearing loss had evidence of ENL reaction. Vestibular involvement was not detected in any of the cases. Evaluation of audiovestibular function was also carried out in 50 fresh cases of leprosy and after 3 months, 6 months and 1 year of multidrug therapy to ascertain any ototoxic side effects of antileprosy drugs. No audiovestibular dysfunction was detected in these patients at any time during follow-up.</p>  a0254-9395